Common Contracts
3 similar Exclusive License Agreement contracts by Menlo Therapeutics, Inc.
EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and TIGERCAT PHARMA, INC. (and, for purposes of Sections 9.01 and11.02, VELOCITY PHARMACEUTICAL HOLDINGS, LLC)Exclusive License Agreement • January 18th, 2018 • Menlo Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”), dated as of December 21, 2012 (the “Effective Date”), is by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“Merck”), TIGERCAT PHARMA, INC., a corporation organized and existing under the laws of Delaware (“Tigercat”) and, for purposes of Sections 9.01 and 11.02 only, VELOCITY PHARMACEUTICAL HOLDINGS, LLC, a corporation organized and existing under the laws of Delaware (“VPH”). Merck and Tigercat are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and TIGERCAT PHARMA, INC. (and, for purposes of Sections 9.01 and11.02, VELOCITY PHARMACEUTICAL HOLDINGS, LLC)Exclusive License Agreement • December 28th, 2017 • Menlo Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”), dated as of December 21, 2012 (the “Effective Date”), is by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“Merck”), TIGERCAT PHARMA, INC., a corporation organized and existing under the laws of Delaware (“Tigercat”) and, for purposes of Sections 9.01 and 11.02 only, VELOCITY PHARMACEUTICAL HOLDINGS, LLC, a corporation organized and existing under the laws of Delaware (“VPH”). Merck and Tigercat are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and TIGERCAT PHARMA, INC. (and, for purposes of Sections 9.01 and11.02, VELOCITY PHARMACEUTICAL HOLDINGS, LLC)Exclusive License Agreement • October 30th, 2017 • Menlo Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”), dated as of December 21, 2012 (the “Effective Date”), is by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“Merck”), TIGERCAT PHARMA, INC., a corporation organized and existing under the laws of Delaware (“Tigercat”) and, for purposes of Sections 9.01 and 11.02 only, VELOCITY PHARMACEUTICAL HOLDINGS, LLC, a corporation organized and existing under the laws of Delaware (“VPH”). Merck and Tigercat are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
